# Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/dabigatran-etexilate-versus-warfarin-in-management-of-non-valvular-atrial/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Joshua Pink,Steven Lane,Munir Pirmohamed,Dyfrig Hughes |
| Citations | 214 |
| DOI | 10.1136/bmj.d6333 |
| Fields | Economics, Econometrics and Finance,Medicine,Pharmacology, Toxicology and Pharmaceutics |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.bmj.com/content/bmj/343/bmj.d6333.full.pdf |
| OpenAlex ID | https://openalex.org/W2022149251 |
| PMID | 22042753 |
| Type | article |
| Year | 2011 |

## Paper authors

- [Dyfrig Hughes](https://scholariq.org/researchers/dyfrig-hughes/)

## Paper journal

- [BMJ](https://scholariq.org/journals/bmj/)

## Paper primary topic

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)

## Paper topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Pharmacovigilance and Adverse Drug Reactions](https://scholariq.org/topics/pharmacovigilance-and-adverse-drug-reactions/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.